Receiving and Unpacking Hazardous Drugs Under USP <800>

USP <800> distinguishes hazardous drug receiving and unpacking from compounding. NIOSH Table 1 antineoplastic hazardous drugs and all hazardous drug active pharmaceutical ingredients are unpacked in a neutral or negative-pressure area, not in a sterile compounding or positive-pressure area. Facility SOPs define damaged-container response and use risk-based controls.

Why unpacking is part of the safety plan

A shipping carton can be damaged, wet, or contaminated before it reaches the pharmacy. Opening it in the wrong location may spread residue into patient-care areas or a cleanroom. USP <800> addresses the hazardous drug lifecycle, including receipt, storage, compounding, administration, and disposal. Receiving staff need to know which products trigger the unpacking procedure and where the designated area is.

Which drugs require particular care

USP’s January 2026 FAQ states that NIOSH Table 1 antineoplastic hazardous drugs and all hazardous drug active pharmaceutical ingredients should be unpacked in a neutral/normal or negative-pressure area. A facility may designate an area; it does not necessarily need to be a separate room. The crucial boundary is that external shipping containers for these items should not be unpacked in sterile compounding or positive-pressure areas.

Neutral or negative pressure: the purpose

A neutral or negative-pressure location helps prevent airborne material from being pushed from the unpacking area into adjacent cleaner or occupied spaces. The room’s pressure relationship is one engineering control among work practices and PPE. Follow the posted designation and room monitoring requirements. Do not choose a convenient counter in a positive-pressure buffer room simply because the package looks intact.

A receiving workflow

At delivery, staff identify shipments that contain hazardous drugs, inspect the outer shipping package, and move the package to the designated unpacking area according to SOP. The employee uses the required PPE and carefully opens the external container without crushing or shaking inner packages. They check for visible damage or leakage, separate clean packaging from drug containers, and route items to their approved storage location. They document receipt and any condition concerns.

Damaged or leaking packages

USP FAQ guidance calls for a tiered evaluation of the incoming hazardous drug container’s integrity; the facility SOP defines the response based on its design and drug types. A crushed outer carton may require inspection, while a leaking or visibly contaminated package can require isolation and spill procedures. Do not handle a suspected leak as routine waste. Restrict access, notify the designated supervisor, use the hazardous drug spill plan, and preserve required incident documentation.

Segregation and routing

Once unpacked, hazardous drugs are stored according to their properties and the facility’s risk assessment, with appropriate segregation and containment. Keep hazardous drug products from being mistakenly placed with ordinary stock. Ensure labels and package identity remain visible. If a product requires refrigeration, use an approved containment approach that avoids contaminating the refrigerator or its contents. Follow USP <800> and facility procedures for storage and handling.

Who does what

Technicians may receive and route stock when trained and assigned, but should not decide independently that a damaged package is safe to use. A pharmacist or designated safety lead provides direction for disposition. Staff should know who to contact during every shift and where the spill kit and emergency instructions are. Training should cover normal handling, damaged package recognition, PPE, and incident reporting.

Common errors

Do not open hazardous drug shipping containers in a sterile compounding or positive-pressure space. Do not assume that every drug labeled “chemotherapy” is the only hazardous drug, or that a sealed inner vial makes the outer carton safe. Do not clean a spill with an ordinary wipe and return the drug to stock. Do not put a questionable item into inventory before the integrity check is complete.

Exam scenario

A delivery contains a Table 1 antineoplastic drug. The sterile compounding buffer room is nearby, so an employee proposes unpacking the carton there. The appropriate response is to use the designated neutral or negative-pressure area in accordance with USP <800> and local SOP. If the package shows damage, stop routine processing and initiate the facility’s evaluation and response procedure.

PTCE takeaway

Identify hazardous shipments, unpack specified HDs in neutral/normal or negative-pressure areas, keep external shipping containers out of sterile compounding and positive-pressure spaces, and follow SOP for container integrity and damage. Use appropriate PPE and escalation. USP <800> and current NIOSH guidance, not convenience, govern the workflow.

Operational detail to remember

Before a shipment arrives, the receiving team should know which delivery location is approved, where required PPE is kept, and who responds to a damaged package. The receiving area should not become an ad hoc staging site that blocks exits or mixes hazardous and ordinary stock. Keep the shipping documentation available for identification, but avoid unnecessary handling of the outside carton. If an inner container is intact but the external package has suspicious powder or liquid, treat the situation as a potential exposure and follow the spill procedure. After unpacking, contaminated packaging is managed according to the pharmacy’s hazardous drug waste procedure. Clean hands and surfaces as required before moving to other work. The exact response is determined by the facility’s documented plan and the product involved.

Key points to carry into practice

• USP <800> distinguishes hazardous drug receiving and unpacking from compounding. NIOSH Table 1 antineoplastic hazardous drugs and all hazardous drug active pharmaceutical ingredients are unpacked in a neutral or negative-pressure area, not in a sterile compounding or positive-pressure area. Facility SOPs define damaged-container response and use risk-based controls.
• Check the current official standard, payer guidance, or facility SOP for the exact requirement.
• Pause and escalate uncertainty instead of extending a date, bypassing a claim edit, or improvising a safety procedure.